Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Assets Average (2016 - 2025)

Historic Assets Average for Ascendis Pharma A (ASND) over the last 12 years, with Q3 2025 value amounting to $1.3 billion.

  • Ascendis Pharma A's Assets Average rose 2793.18% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 2793.18%. This contributed to the annual value of $1.1 billion for FY2024, which is 824.02% up from last year.
  • As of Q3 2025, Ascendis Pharma A's Assets Average stood at $1.3 billion, which was up 2793.18% from $1.2 billion recorded in Q2 2025.
  • In the past 5 years, Ascendis Pharma A's Assets Average registered a high of $1.9 billion during Q1 2022, and its lowest value of $844.2 million during Q2 2024.
  • Its 5-year average for Assets Average is $1.2 billion, with a median of $1.2 billion in 2025.
  • In the last 5 years, Ascendis Pharma A's Assets Average soared by 6803.09% in 2021 and then crashed by 4391.36% in 2023.
  • Quarter analysis of 5 years shows Ascendis Pharma A's Assets Average stood at $1.9 billion in 2021, then plummeted by 35.37% to $1.2 billion in 2022, then fell by 23.25% to $919.4 million in 2023, then skyrocketed by 33.87% to $1.2 billion in 2024, then increased by 4.87% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q3 2025, $1.2 billion for Q2 2025, and $1.2 billion during Q1 2025.